Cobicistat Patent Expiration
Cobicistat is Used for treating HIV infection by enhancing the pharmacokinetics and inhibiting cytochrome P450 monooxygenase. It was first introduced by Gilead Sciences Inc
Cobicistat Patents
Given below is the list of patents protecting Cobicistat, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tybost |
US10039718 (Pediatric) | Use of solid carrier particles to improve the processability of a pharmaceutical agent | Apr 06, 2033 | Gilead Sciences Inc |
| Tybost | US10039718 | Use of solid carrier particles to improve the processability of a pharmaceutical agent | Oct 06, 2032 | Gilead Sciences Inc |
| Tybost |
US8148374 (Pediatric) | Modulators of pharmacokinetic properties of therapeutics | Mar 03, 2030 | Gilead Sciences Inc |
| Tybost | US8148374 | Modulators of pharmacokinetic properties of therapeutics | Sep 03, 2029 | Gilead Sciences Inc |
Cobicistat's Family Patents
Explore Our Curated Drug Screens
Cobicistat Generic API Manufacturers
Only one generic application has been filed for Cobicistat.
Given below is the list of companies who have filed for Cobicistat generic, along with the locations of their manufacturing plants worldwide.
1. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Cobicistat. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 150MG | tablet | Discontinued | ORAL | N/A | Feb 7, 2024 |